Zobrazeno 1 - 4
of 4
pro vyhledávání: '"M. A. Sigov"'
Autor:
A. Yu. Shurinov, E. V. Borodavina, V. V. Krylov, M. A. Sigov, A. A. Rodichev, S. A. Ivanov, A. D. Kaprin
Publikováno v:
Опухоли головы и шеи, Vol 14, Iss 1, Pp 83-95 (2024)
The radioiodine therapy is a one of the basic elements at combined treatment of differentiated thyroid cancer and is an alternative method for patients with distant metastases and a potentially high risk of tumor recurrence. It has been used in clini
Externí odkaz:
https://doaj.org/article/eea633820cb246259d0b71efd61775b1
Autor:
F. E. Sevryukov, V. V. Polkin, Yu. A. Panaseikin, M. A. Sigov, R. F. Zibirov, I. A. Bekhtereva, S. A. Ivanov, A. D. Kaprin
Publikováno v:
Опухоли головы и шеи, Vol 13, Iss 4, Pp 37-47 (2024)
Introduction. Head and neck cancer is the 7th most common malignancy worldwide; squamous cell carcinoma of the oral mucosa are almost a third of tumors of that localization. Metastatic lesions of the neck lymph nodes are an unfavorable prognostic fac
Externí odkaz:
https://doaj.org/article/d0c06a5d05c24639b915b1b31fd6e5cc
Autor:
A. D. Kaprin, S. A. Ivanov, V. V. Kucherov, A. P. Petrosyan, K. V. Mayorov, N. V. Markov, L. O. Petrov, G. A. Davydov, M. A. Sigov, N. K. Silantieva, T. P. Berezovskaya, A. Yu. Usacheva, D. B. Sanin
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 29, Iss 5, Pp 7-12 (2019)
Recent years have seen an increase in the number of patients with malignant tumours of the liver. In this context, new treatment methods are being actively introduced into practice, one of which is liver radioembolization utilizing microspheres embed
Externí odkaz:
https://doaj.org/article/894c6333c5594d7eb3b2f21dc92325dc
Autor:
V. V. Krylov, N. S. Legkodimova, T. Yu. Kochetova, V. M. Petriev, M. A. Sigov, V. K. Tishchenko, A. I. Pronin, A. Yu. Shurinov, K. M. Petrosyan, O. N. Spichenkova, O. B. Karyakin, V. A. Biryukov, V. F. Stepanenko, O. P. Vlasova, P. V. Shegaj, S. A. Ivanov, A. D. Kaprin
Publikováno v:
Diagnostic radiology and radiotherapy. 13:75-85
INTRODUCTION: The results of studies of clinical potential of a new domestic radiopharmaceutical 177Lu-DOTA-PSMA in patients with metastatic castration-resistant prostate cancer are presented in this article.OBJECTIVE: The pharmacokinetics, safety an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdb57b61a11e365eb7351e7acaa6c859
https://doi.org/10.22328/2079-5343-2022-13-4-75-85
https://doi.org/10.22328/2079-5343-2022-13-4-75-85